525 related articles for article (PubMed ID: 110184)
1. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Long MW; Snider DE; Farer LS
Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
[TBL] [Abstract][Full Text] [Related]
2. Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.
Snider DE; Long MW; Cross FS; Farer LS
Am Rev Respir Dis; 1984 Apr; 129(4):573-9. PubMed ID: 6370060
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Wada M
Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
[TBL] [Abstract][Full Text] [Related]
5. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Grönhagen-Riska C; Hellstrom PE; Fröseth B
Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
7. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(4):193-205. PubMed ID: 204971
[TBL] [Abstract][Full Text] [Related]
8. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of rifampin in newly detected pulmonary tuberculosis.
Jessamine AG; Gale GL; Eidus L
Can Med Assoc J; 1974 May; 110(9):1033-7. PubMed ID: 4207234
[TBL] [Abstract][Full Text] [Related]
12. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
Newman R; Doster BE; Murray FJ; Woolpert SF
Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
[No Abstract] [Full Text] [Related]
13. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
Jeanes CW; Jessamine AG; Eidus L
Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
[TBL] [Abstract][Full Text] [Related]
14. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
Slutkin G; Schecter GF; Hopewell PC
Am Rev Respir Dis; 1988 Dec; 138(6):1622-4. PubMed ID: 3144221
[TBL] [Abstract][Full Text] [Related]
15. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
Dutt AK; Moers D; Stead WW
Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
[TBL] [Abstract][Full Text] [Related]
16. Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
Dutt AK; Moers D; Stead WW
Am J Med; 1984 Aug; 77(2):233-42. PubMed ID: 6431810
[TBL] [Abstract][Full Text] [Related]
17. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
Newman R; Doster B; Murray FJ; Ferebee S
Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459
[No Abstract] [Full Text] [Related]
18. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
19. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
Zierski M; Bek E; Long MW; Snider DE
Am Rev Respir Dis; 1980 Dec; 122(6):879-89. PubMed ID: 7006476
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
Semenova OV
Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
